2016
DOI: 10.1016/j.npep.2015.11.090
|View full text |Cite
|
Sign up to set email alerts
|

Effect of nicotinic acetylcholine receptor alpha 1 (nAChRα1) peptides on rabies virus infection in neuronal cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 36 publications
0
6
0
Order By: Relevance
“…We also tested the binding of RABV-G-DFuLp to the RABV receptor using the 32-mer peptide derived from nAchR via surface plasmon resonance (SPR). Several reports have shown that RABV infection could be inhibited, via specific G/peptide interactions, by the torpedo peptide (T32) with the highest potency, by the bovine peptide (C32) with less efficiency, and by the human peptide (H32) with the least efficacy (Sajjanar et al, 2017(Sajjanar et al, , 2016. Falling in good accordance with these studies, RABV-G-DFuLp interacted most effectively with T32 (with an affinity of 1.7 mM in K D ) and less potently with C32 (3.1 mM in K D ) and only showed a marginal binding to H32 (>70 mM in K D ) ( Figure 1E).…”
Section: Preparation Of a Well-behaved Rabv-g Ecto-domain Proteinmentioning
confidence: 99%
“…We also tested the binding of RABV-G-DFuLp to the RABV receptor using the 32-mer peptide derived from nAchR via surface plasmon resonance (SPR). Several reports have shown that RABV infection could be inhibited, via specific G/peptide interactions, by the torpedo peptide (T32) with the highest potency, by the bovine peptide (C32) with less efficiency, and by the human peptide (H32) with the least efficacy (Sajjanar et al, 2017(Sajjanar et al, , 2016. Falling in good accordance with these studies, RABV-G-DFuLp interacted most effectively with T32 (with an affinity of 1.7 mM in K D ) and less potently with C32 (3.1 mM in K D ) and only showed a marginal binding to H32 (>70 mM in K D ) ( Figure 1E).…”
Section: Preparation Of a Well-behaved Rabv-g Ecto-domain Proteinmentioning
confidence: 99%
“…The patient had neutralizing antibodies at the time of admitting to hospital and her therapeutic protocol for coma included midazolam and supplemental phenobarbital, and supportive treatment like ketamine, ribavirin and amantadine (Jackson 2016). Sajjanar et al (2016) reported that nicotinic acetylcholine receptor alpha 1 (nAChRa1) subunit peptides had specific affinity towards the RABV and these receptors may act as receptor decoy molecules results in inhibition of attachment of RABV to the neuronal cell receptors, which ultimately decrease viral replication. Torpedo peptide sequence (T-32) showed more antiviral action when compared to bovine, human and rat peptide sequences (Sajjanar et al 2016).…”
Section: Theraputic Approachesmentioning
confidence: 99%
“…Sajjanar et al (2016) reported that nicotinic acetylcholine receptor alpha 1 (nAChRa1) subunit peptides had specific affinity towards the RABV and these receptors may act as receptor decoy molecules results in inhibition of attachment of RABV to the neuronal cell receptors, which ultimately decrease viral replication. Torpedo peptide sequence (T-32) showed more antiviral action when compared to bovine, human and rat peptide sequences (Sajjanar et al 2016).…”
Section: Theraputic Approachesmentioning
confidence: 99%
“…Of note, deficiency of T cell CAChT in mice promotes T cell exhaustion during viral infections. Therefore, the expression of CAChT and ACh in the immune cells is necessary to combat viral infections (Sajjanar et al 2016 ).…”
Section: Cholinergic System and Viral Infectionsmentioning
confidence: 99%